Having regard to the Treaty establishing the European Community,

Having regard to Council Decision 90/424/EEC of 26 June 1990 on expenditure in the veterinary field (1), and in particular Article 28(2) thereof,

Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (2), and in particular Article 32(7) thereof,

Article 1

For classical swine fever, the Community grants financial assistance to the Institut für Virologie der Tierärztlichen Hochschule, Hannover, Germany, to carry out the functions and duties referred to in Annex IV to Directive 2001/89/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 232 000 for the period from 1 January to 31 December 2007, of which a maximum of EUR 18 000 shall be dedicated to the organisation of a technical workshop on classical swine fever diagnostic techniques.

Article 2

For Newcastle disease, the Community grants financial assistance to the Central Veterinary Laboratory, Addlestone, United Kingdom, to carry out the functions and duties referred to in Annex V to Directive 92/66/EEC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 77 000 for the period from 1 January to 31 December 2007.

Article 3

For avian influenza, the Community grants financial assistance to the Central Veterinary Laboratory, Addlestone, United Kingdom, to carry out the functions and duties referred to in Annex V to Directive 92/40/EEC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 406 000 for the period from 1 January to 31 December 2007.

Article 4

For swine vesicular disease, the Community grants financial assistance to the Pirbright Laboratory, United Kingdom, to carry out the functions and duties referred to in Annex III to Directive 92/119/EEC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 126 000 for the period from 1 January to 31 December 2007.

Article 5

For foot and mouth disease, the Community grants financial assistance to the Pirbright Laboratory, United Kingdom, to carry out the functions and duties referred to in Annex XVI to Directive 2003/85/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 274 000 for the period from 1 January to 31 December 2007.

Article 6

For fish diseases, the Community grants financial assistance to the Danish National Veterinary Institute, Aarhus, Denmark, to carry out the functions and duties referred to in Annex C to Directive 93/53/EEC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 150 000 for the period from 1 January to 31 December 2007.

Article 7

For diseases of bivalve molluscs, the Community grants financial assistance to the Ifremer, La Tremblade, France, to carry out the functions and duties referred to in Annex B to Directive 95/70/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 90 000 for the period from 1 January to 31 December 2007.

Article 8

For African horse sickness, the Community grants financial assistance to the Laboratorio central de veterinaria de Madrid, Algete, Spain, to carry out the functions and duties referred to in Annex I to Directive 92/35/EEC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 98 000 for the period from 1 January to 31 December 2007, of which a maximum of EUR 38 000 shall be dedicated to the organisation of a technical workshop on African horse sickness diagnostic techniques.

Article 9

For bluetongue, the Community grants financial assistance to the Pirbright Laboratory, United Kingdom, to carry out the functions and duties referred to in Annex II to Directive 2000/75/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 373 000 for the period from 1 January to 31 December 2007, of which a maximum of EUR 45 000 shall be dedicated to the organisation of a technical workshop on bluetongue diagnostic techniques.

Article 10

For rabies serology, the Community grants financial assistance to the laboratory of the l’Agence française de sécurité sanitaire des aliments (AFSSA), Nancy, France, to carry out the functions and duties referred to in Annex II to Decision 2000/258/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 200 000 for the period from 1 January to 31 December 2007.

Article 11

For brucellosis, the Community grants financial assistance to the AFSSA — Laboratoire d’études et de recherches en pathologie animale et zoonoses, Maisons-Alfort, France, to carry out the functions and duties referred in Article 32(2) of Regulation (EC) No 882/2004.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 250 000 for the period from 1 January to 31 December 2007, of which a maximum of EUR 35 000 shall be dedicated to the organisation of a technical workshop on brucellosis diagnostic techniques.

Article 12

For African swine fever, the Community grants financial assistance to the Centro de Investigación en Sanidad Animal, Valdeolmos, Madrid, Spain, to carry out the functions and duties referred to in Annex V to Directive 2002/60/EC.

The Community’s financial assistance shall be at the rate of 100 % of the elegible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that research centre for the work programme and shall amount to a maximum of EUR 120 000 for the period from 1 January to 31 December 2007.

Article 13

For the assessment of the results of the methods of testing pure-bred breeding animals of the bovine species, and the harmonisation of the various methods of testing, the Community grants financial assistance to the Interbull Centre, Uppsala, Sweden, to carry out the functions and duties referred to in Annex II to Decision 96/463/EC.

The Community’s financial assistance shall be at the rate of 100 % of the costs to be incurred by that centre for the work programme and shall amount to a maximum of EUR 80 000 for the period from 1 January to 31 December 2007.

Article 14

This Decision is addressed to: